In recent years clinical cancer genetics has become increasingly important. Several events, in particular the developments in DNA-based technology, have contributed to this evolution. Clinical cancer genetics has now matured to a medical discipline which is truly multidisciplinary in which clinical and molecular geneticists work together with clinical and medical oncologists as well as with psycho-social workers.

Due to the multidisciplinary nature of clinical cancer genetics most papers are currently being published in a wide variety of journals on epidemiology, oncology and genetics. Familial Cancer provides a forum bringing these topics together focusing on the interests and needs of the clinician.

The journal mainly concentrates on clinical cancer genetics. Most major areas in the field shall be included, such as epidemiology of familial cancer, molecular analysis and diagnosis, clinical expression, treatment and prevention, counselling and the health economics of familial cancer.

Familial Cancer publishes Original Articles, Reviews, Short Communications, Book Reviews, and Letters to the Editor.

Editor-in-Chief:
Fred H. Menko
Family Cancer Clinic, Antoni van Leeuwenhoek/ Netherlands Cancer Institute, Amsterdam, The Netherlands
Hans F.A. Vasen
The Netherlands Foundation for the Detection of Hereditary Tumours, Leiden University Medical Center, The Netherlands
Associate Editor:
D.T. Bishop
St. James's University Hospital, Leeds, UK
C. R. Boland
Baylor University Medical Center, Dallas, TX, USA
J.E. Garber
Dana-Farber Cancer Institute, Boston, MA, USA
S. Narod
Womens College Research Institute, Toronto,ON, Canada
I. Tomlinson
University of Oxford, UK
Editorial Board Members:

L. A. Aaltonen, Helsinki, Finland; I. Blanco, Barcelona, Spain; J. Burn, Newcastle upon Tyne, UK; G. Capellá, L'Hospitalet de Llobregat,Spain; F. Carneiro, Porto, Portugal; A. de la Chapelle, Columbus, OH, USA; P. Devilee, Leiden, The Netherlands; D.F. Easton, Cambridge, UK; R. Eeles, London, UK; D.G.R. Evans,Manchester, UK; D.E. Goldgar, Lyon, France; H. Hampel, Columbus, OH, USA; S. Hodgson, London, UK; A. Latchford, London, UK; K. H. Lu, Houston, TX, USA; P. Lynch, Houston, TX, USA; F. Macrae, Victoria, Australia; E. Maher, Cambridge, UK; J.-P. Mecklin, Jyväskylä, Finland; B. Meiser, Randwick NSW Australia; P. Møller, Oslo, Norway; G. Moslein, Witten, Germany; M.A. Rodriguez-Bigas, Houston, TX, USA; L. Schmidt, Bethesda, MD,USA; S. Syngal, Boston, MA, USA; G. D. Valk, Utrecht, The Netherlands; B.L. Weber, Philadelphia, PA, USA